323 related articles for article (PubMed ID: 833472)
21. Comparative effects of ursodeoxycholic acid and chenodeoxycholic acid on bile acid kinetics and biliary lipid secretion in humans. Evidence for different modes of action on bile acid synthesis.
Nilsell K; Angelin B; Leijd B; Einarsson K
Gastroenterology; 1983 Dec; 85(6):1248-56. PubMed ID: 6628924
[TBL] [Abstract][Full Text] [Related]
22. Normalization of low-density-lipoprotein levels in heterozygous familial hypercholesterolemia with a combined drug regimen.
Kane JP; Malloy MJ; Tun P; Phillips NR; Freedman DD; Williams ML; Rowe JS; Havel RJ
N Engl J Med; 1981 Jan; 304(5):251-8. PubMed ID: 7003391
[TBL] [Abstract][Full Text] [Related]
23. Effect of clofibrate and colestipol singly and in combination on plasma lipids and lipoproteins in type III hyperlipoproteinemia.
Hoogwerf BJ; Peters JR; Frantz ID; Hunninghake DB
Metabolism; 1985 Oct; 34(10):978-81. PubMed ID: 4046841
[TBL] [Abstract][Full Text] [Related]
24. Comparison of the effects of colestipol hydrochloride and clofibrate on plasma lipids and lipoproteins in the treatment of hypercholesterolemia.
Seplowitz AH; Smith FR; Berns L; Eder HA; Goodman DS
Atherosclerosis; 1981 Apr; 39(1):35-43. PubMed ID: 7018502
[TBL] [Abstract][Full Text] [Related]
25. Effects of low dose chenodeoxycholic acid feeding on biliary lipid metabolism.
Adler RD; Bennion LJ; Duane WC; Grundy SM
Gastroenterology; 1975 Feb; 68(2):326-34. PubMed ID: 1116678
[TBL] [Abstract][Full Text] [Related]
26. Effects of tegaserod on bile composition and hepatic secretion in Richardson ground squirrels on an enriched cholesterol diet.
Mathison R; Shaffer E; Pfannkuche HJ; Earnest D
Lipids Health Dis; 2006 Jun; 5():15. PubMed ID: 16792807
[TBL] [Abstract][Full Text] [Related]
27. Hepatic cholesterol and bile acid synthesis, low-density lipoprotein receptor function, and plasma and fecal sterol levels in mice: effects of apolipoprotein E deficiency and probucol or phytosterol treatment.
Moghadasian MH; Nguyen LB; Shefer S; Salen G; Batta AK; Frohlich JJ
Metabolism; 2001 Jun; 50(6):708-14. PubMed ID: 11398149
[TBL] [Abstract][Full Text] [Related]
28. Regulation of biliary cholesterol secretion. Functional relationship between the canalicular and sinusoidal cholesterol secretory pathways in the rat.
Nervi F; Marinović I; Rigotti A; Ulloa N
J Clin Invest; 1988 Dec; 82(6):1818-25. PubMed ID: 3198756
[TBL] [Abstract][Full Text] [Related]
29. Effect of ileal autotransplantation on cholesterol, bile acids, and biliary lipids in pigs with proximal small bowel resection.
Pakarinen M; Miettinen TA; Kuusanmäki P; Vento P; Kivistö T; Halttunen J
Hepatology; 1997 Jun; 25(6):1315-22. PubMed ID: 9185745
[TBL] [Abstract][Full Text] [Related]
30. Exercise enhances whole-body cholesterol turnover in mice.
Meissner M; Havinga R; Boverhof R; Kema I; Groen AK; Kuipers F
Med Sci Sports Exerc; 2010 Aug; 42(8):1460-8. PubMed ID: 20139791
[TBL] [Abstract][Full Text] [Related]
31. Comparison of hypocholesterolemic activities of the bile acid sequestrants cholestyramine and colestipol hydrochloride in cholesterol fed SEA quail.
Day CE
Artery; 1990; 17(5):281-8. PubMed ID: 2396902
[TBL] [Abstract][Full Text] [Related]
32. Effect of bile acid conjugation pattern on bile acid metabolism in normal humans.
Hardison WG; Grundy SM
Gastroenterology; 1983 Mar; 84(3):617-20. PubMed ID: 6822329
[TBL] [Abstract][Full Text] [Related]
33. Effects of colestipol, clofibrate, and placebo on plasma lipoproteins of patients with hypercholesterolemia.
Crouse JR; Grundy SM
Metabolism; 1981 Feb; 30(2):123-8. PubMed ID: 7464561
[TBL] [Abstract][Full Text] [Related]
34. Effect of treatment with a bile-sequestering agent (Secholex) on intestinal absorption, duodenal bile acids, and plasma lipids.
Ritland S; Fausa O; Gjone E; Blomhoff JP; Skrede S; Lanner A
Scand J Gastroenterol; 1975; 10(8):791-800. PubMed ID: 173015
[TBL] [Abstract][Full Text] [Related]
35. [Colestipol by hypercholesteremia in diabetics].
Düntsch G
Fortschr Med; 1977 Jun; 95(22):1492-6. PubMed ID: 873435
[TBL] [Abstract][Full Text] [Related]
36. Probucol further lowers the serum cholesterol of colestipol-treated patients with hypercholesterolemia.
Schonfeld G; Witztum J; Basich P
Artery; 1982; 10(2):99-104. PubMed ID: 7092583
[TBL] [Abstract][Full Text] [Related]
37. Correlating metabolism of plasma and tissue cholesterol with that of plasma-lipoproteins.
Sodhi HS; Kudchodkar BJ
Lancet; 1973 Mar; 1(7802):513-9. PubMed ID: 4119950
[No Abstract] [Full Text] [Related]
38. Effects of colestipol hydrochloride on cholesterol and bile acids absorption in the rat intestinal tract.
Fujihashi T; Munekiyo K; Meshi T
J Pharmacobiodyn; 1981 Aug; 4(8):552-8. PubMed ID: 7299619
[TBL] [Abstract][Full Text] [Related]
39. Long-term trial with colestipol plus clofibrate in familial hypercholesterolemia.
Fellin R; Baggio G; Briani G; Baiocchi MR; Manzato E; Baldo G; Crepaldi G
Atherosclerosis; 1978 Feb; 29(2):241-9. PubMed ID: 348207
[TBL] [Abstract][Full Text] [Related]
40. Biliary lipid composition during treatment with different hypolipidaemic drugs.
Angelin B; Einarsson K; Leijd B
Eur J Clin Invest; 1979 Jun; 9(3):185-90. PubMed ID: 113218
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
